{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:25:29Z","timestamp":1711844729120},"reference-count":17,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,3,30]]},"DOI":"10.1536\/ihj.23-167","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T22:12:16Z","timestamp":1710195136000},"page":"230-236","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions"],"prefix":"10.1536","volume":"65","author":[{"given":"Michiaki","family":"Higashitani","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University Ibaraki Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ueshima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kameda Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Saiseikai Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Takatsu General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Hirokami","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teine Keijinkai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Tsubakimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Sakurakai Takahashi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasukabe Chuo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Song P, Rudan D, Zhu Y, <i>et al<\/i>. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019; 7: e1020-30.","DOI":"10.1016\/S2214-109X(19)30255-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamauchi Y, Takahara M, Shintani Y, <i>et al<\/i>. One-year outcomes of endovascular therapy for aortoiliac lesions. Circ Cardiovasc Interv 2019; 12: e007441.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007441"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa S. 15-year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv 2015; 8: 1893-901.","DOI":"10.1016\/j.jcin.2015.08.020"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ko T, Higashitani M, Uemura Y, <i>et al<\/i>. Clinical outcome and diverse risk factors for different therapeutic target locations of peripheral artery disease. J Atheroscler Thromb 2020; 27: 769-79.","DOI":"10.5551\/jat.52647"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Aboyans V, Ricco JB, Bartelink ML, <i>et al<\/i>. Editor&apos;s choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018; 55: 305-68.","DOI":"10.1016\/j.ejvs.2018.03.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schillinger M, Sabeti S, Loewe C, <i>et al<\/i>. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-88.","DOI":"10.1056\/NEJMoa051303"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chowdhury MM, McLain AD, Twine CP. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Database Syst Rev 2014; 2014: CD006767.","DOI":"10.1002\/14651858.CD006767.pub3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kasapis C, Henke PK, Chetcuti SJ, <i>et al<\/i>. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2009; 30: 44-55.","DOI":"10.1093\/eurheartj\/ehn514"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ding Y, Zhou M, Wang Y, Cai L, Shi Z. Comparison of drug-eluting stent with bare-metal stent implantation in femoropopliteal artery disease: a systematic review and meta-analysis. Ann Vasc Surg 2018; 50: 96-105.","DOI":"10.1016\/j.avsg.2017.12.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lee YJ, Kook H, Ko YG, <i>et al<\/i>. Drug eluting stent vs. drug coated balloon for native femoropopliteal artery disease: a two centre experience. Eur J Vasc Endovasc Surg 2021; 61: 287-95.","DOI":"10.1016\/j.ejvs.2020.10.008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suzuki K, Ueshima D, Higashitani M, <i>et al<\/i>. Two-year results of endovascular therapy for femoropopliteal artery disease in Japan during the introduction of drug-eluting devices. Cardiovasc Interv Ther 2023; 38: 113-20.","DOI":"10.1007\/s12928-022-00873-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kanda Y. Investigation of the freely available easy-to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant 2013; 48: 452-8.","DOI":"10.1038\/bmt.2012.244"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Mehran R, Baber U, Steg PG, <i>et al<\/i>. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013; 382: 1714-22.","DOI":"10.1016\/S0140-6736(13)61720-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fujihara M, Takahara M, Sasaki S, <i>et al<\/i>. Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 2017; 24: 367-75.","DOI":"10.1177\/1526602817698634"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Schroeder H, Werner M, Meyer DR, <i>et al<\/i>. Low-dose paclitaxel-coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the ILLUMENATE European Randomized Clinical Trial (randomized trial of a novel paclitaxel-coated percutaneous angioplasty balloon). Circulation 2017; 135: 2227-36.","DOI":"10.1161\/CIRCULATIONAHA.116.026493"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Giacoppo D, Cassese S, Harada Y, <i>et al<\/i>. Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials. JACC Cardiovasc Interv 2016; 9: 1731-42.","DOI":"10.1016\/j.jcin.2016.06.008"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/2\/65_23-167\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T04:44:19Z","timestamp":1711773859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/2\/65_23-167\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-167","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"article-number":"23-167"}}